Breast cancer Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Carrier of pathogenic or likely pathogenic variant (class 4 or 5) in BRCA1 or BRCA2 2. Born after 1920 3. Aged at least 18 years at cohort entry 4. No personal history of cancer (except cervix carcinoma in situ or non-melanoma skin cancer) at cohort entry 5. No personal history of risk-reducing bilateral mastectomy at cohort entry
Exclusion criteria
Exclusion criteria: No follow-up information available
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnosis of invasive breast cancer or ductal carcinoma in situ (DCIS) derived from self-report (in follow-up questionnaires), pathology reports, medical records and linkages to cancer registries at any time during follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
Australia, Austria, Canada, Czech Republic, England, France, Germany, Hungary, Netherlands, New Zealand, Norway, Poland, Spain, Sweden, United Kingdom, United States of America